Advances in Mesoporous Silica Nanoparticles for Targeted and Controlled Drug Delivery

Authors

https://doi.org/10.48313/bic.v2i4.49

Abstract

Mesoporous Silica Nanoparticles (MSNs) have emerged as a versatile and highly tunable platform for controlled and targeted therapeutic applications. Their unique structural features including high surface area, tunable pore size, adjustable morphology, and abundant surface silanol groups enable efficient drug loading, precise surface functionalization, and stimuli-responsive release. Advances in synthesis methods, including sol-gel, soft-template, hard-template, and microemulsion approaches, allow precise control over particle size, pore architecture, and surface properties, which are critical for optimizing biological performance. Surface functionalization strategies, such as post-synthesis grafting, co-condensation, polymer coating, and ligand conjugation, enhance biocompatibility, targeting efficiency, and controlled drug release, while minimizing premature drug leakage and systemic toxicity. MSNs support diverse drug loading mechanisms, including physical adsorption, covalent attachment, and encapsulation with pore capping, enabling sustained and stimuli-responsive therapeutic release in response to pH, redox potential, enzymes, or external triggers. Targeting strategies, encompassing passive accumulation, active ligand-mediated targeting, biomimetic coatings, and organelle-specific delivery, further enhance therapeutic specificity and efficacy. Despite these advances, challenges remain in clinical translation, including long-term toxicity, immunogenicity, and large-scale reproducible synthesis. Future research is expected to focus on multifunctional, stimuli-responsive, and theragnostic MSNs that integrate combination therapies, biomimetic targeting, and real-time monitoring, thereby advancing personalized and precision medicine. This review provides a comprehensive overview of MSN structure, synthesis, functionalization, drug loading, targeting strategies, and future perspectives, highlighting their potential as next-generation nanotherapeutic platforms.

Keywords:

Mesoporous silica nanoparticles, Controlled drug delivery, Targeted therapeutics, Surface functionalization, Stimuli-responsive release, Nanomedicine

References

  1. [1] Saha, A., Mishra, P., Biswas, G., & Bhakta, S. (2024). Greening the pathways: a comprehensive review of sustainable synthesis strategies for silica nanoparticles and their diverse applications. RSC advances, 14(16), 11197–11216. https://doi.org/10.1039/D4RA01047G

  2. [2] Ostapchuk, G. O. (2024). Eco-friendly synthesis of silica nanoparticles and their applications. Materials research foundations. https://doi.org/10.21741/9781644903261-1

  3. [3] Ibrahim, S. S., Elbehery, H. H., & Samy, A. (2024). The efficacy of green silica nanoparticles synthesized from rice straw in the management of Callosobruchus maculatus (Col., Bruchidae). Scientific reports, 14(1), 8834. https://doi.org/10.1038/s41598-024-58856-4

  4. [4] Wei, L., Fan, Y., Lin, H., & Che, S. (2024). Synthesis of Anisotropic Silica Nanoparticles. Chemical research in chinese universities, 40(6), 1220–1226. https://doi.org/10.1007/s40242-024-4092-7

  5. [5] Song, X., Segura-Egea, J. J., & Díaz-Cuenca, A. (2023). Sol–Gel technologies to obtain advanced bioceramics for dental therapeutics. Molecules, 28(19), 1-27. https://doi.org/10.3390/molecules28196967

  6. [6] Wang, Y., Li, Z., Ouyang, J., & Karniadakis, G. E. (2020). Controlled release of entrapped nanoparticles from thermoresponsive hydrogels with tunable network characteristics. Soft matter, 16(20), 4756–4766. https://doi.org/10.1039/D0SM00207K

  7. [7] Zhou, X., Liu, Y., Huang, Y., Ma, Y., Lv, J., & Xiao, B. (2019). Mucus-penetrating polymeric nanoparticles for oral delivery of curcumin to inflamed colon tissue. Journal of drug delivery science and technology, 52, 157–164. https://doi.org/10.1016/j.jddst.2019.04.030

  8. [8] Zaid Alkilani, A., McCrudden, M. T., & Donnelly, R. F. (2015). Transdermal drug delivery: Innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics, 7(4), 438–470. https://doi.org/10.3390/pharmaceutics7040438

  9. [9] Piconi, C., & Sprio, S. (2021). Oxide bioceramic composites in orthopedics and dentistry. Journal of composites science, 5(8), 1-13. https://doi.org/10.3390/jcs5080206

  10. [10] Tapeh, S. M. T., Baei, M. S., & Keshel, S. H. (2021). Synthesis of thermogel modified with biomaterials as carrier for hUSSCs differentiation into cardiac cells: Physicomechanical and biological assessment. Materials science and engineering: c, 119, 111517. https://doi.org/10.1016/j.msec.2020.111517

  11. [11] Zafar, M. J., Zhu, D., & Zhang, Z. (2019). 3D Printing of Bioceramics for bone tissue engineering. Materials, 12(20), 1–26. https://doi.org/10.3390/ma12203361

  12. [12] Blatt, S., Thiem, D. G., Kyyak, S., Pabst, A., Al-Nawas, B., & Kämmerer, P. W. (2021). Possible implications for improved osteogenesis? The combination of platelet-rich fibrin with different bone substitute materials. Frontiers in bioengineering and biotechnology, 9, 1-12. https://doi.org/10.3389/fbioe.2021.640053

  13. [13] Elshazly, N., Nasr, F. E., Hamdy, A., Saied, S., & Elshazly, M. (2024). Advances in clinical applications of bioceramics in the new regenerative medicine era. World journal of clinical cases, 12(11), 1863–1869. https://doi.org/10.12998/wjcc.v12.i11.1863

  14. [14] Naghib, S. M., Amiri, S., & Mozafari, M. R. (2024). Stimuli-responsive chitosan-based nanocarriers for drug delivery in wound dressing applications: A review. Carbohydrate polymer technologies and applications, 7, 100497. https://doi.org/10.1016/j.carpta.2024.100497

  15. [15] Safarzadeh, S., Mozafari, M. R., & Naghib, S. M. (2024). Chitosan-incorporated bioceramic-based nanomaterials for localized release of therapeutics and bone regeneration: An overview of recent advances and progresses. Current organic chemistry, 28(15), 1190–1214. https://doi.org/10.2174/0113852728304647240426201554

  16. [16] Wang, X., Xiao, Y., Song, W., Ye, L., Yang, C., Xing, Y., & Yuan, Z. (2023). Clinical application of calcium silicate-based bioceramics in endodontics. Journal of translational medicine, 21(1), 1–16. https://doi.org/10.1186/s12967-023-04550-4

  17. [17] Vaiani, L., Boccaccio, A., Uva, A. E., Palumbo, G., Piccininni, A., Guglielmi, P., … ., & Ballini, A. (2023). Ceramic materials for biomedical applications: An overview on properties and fabrication processes. Journal of functional biomaterials, 14(13), 1-22. https://doi.org/10.3390/jfb14030146

  18. [18] Rezwan, K., Chen, Q. Z., Blaker, J. J., & Boccaccini, A. R. (2006). Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials, 27(18), 3413–3431. https://doi.org/10.1016/j.biomaterials.2006.01.039

  19. [19] Mousavi, A., & Yaghoobi, H. (2025). Ethical challenges of personalized medicine. The second international congress on artificial intelligence in medical sciences, Tehran, Iran. Civilica. (In Persian). https://civilica.com/doc/2310901

  20. [20] Wiwanitkit, V. (2017). Ethics in nanomedicine: A concern on new nanotechnology. Med One, 2(5), e170025. https://doi.org/10.20900/mo.20170025

  21. [21] Ma, F. X., Achagri, G., Zhou, L. C., Hao, B., & Ma, P. C. (2024). Enhanced performance of polyurethane foam with presence of silica nanoparticles. Composites communications, 46, 101841. https://doi.org/10.1016/j.coco.2024.101841

  22. [22] Syed, J., Hakkim, N. L., Nebhani, L., & Gosvami, N. N. (2024). Enhancing tribological properties of lubricated contacts via synergistic interactions of green silica nanoparticles and ZDDP. Tribology international, 197, 109829. https://doi.org/10.1016/j.triboint.2024.109829

  23. [23] Majidi, R. F., Mesgar, A. S. M., & Milan, P. B. (2024). Surface-modified, zinc-incorporated mesoporous silica nanoparticles with improved antibacterial and rapid hemostatic properties. Colloids and surfaces b: Biointerfaces, 243, 114132. https://doi.org/10.1016/j.colsurfb.2024.114132

  24. [24] Nuti, S., Fernández-Lodeiro, A., Galhano, J., Oliveira, E., Duarte, M. P., Capelo-Martínez, J. L., … ., & Fernández-Lodeiro, J. (2024). Tailoring mesoporous silica-coated silver nanoparticles and polyurethane-doped films for enhanced antimicrobial applications. Nanomaterials, 14(5), 1-12. https://doi.org/10.3390/nano14050462

  25. [25] Yu, J., Dan, N., Eslami, S. M., & Lu, X. (2024). State of the art of silica nanoparticles: An overview on biodistribution and preclinical toxicity studies. The AAPS journal, 26(3), 35. https://doi.org/10.1208/s12248-024-00906-w

  26. [26] Mathur, J., & Goswami, P. (2024). Positive impact of green synthesized silica nanoparticles in plant growth promotion and physiological responses of eruca sativa mill. Journal of soil science and plant nutrition, 24(2), 2263–2275. https://doi.org/10.1007/s42729-024-01725-w

  27. [27] Lu, J., Mei, M., & Huang, C. (2025). Influence of silicon dioxide nanoparticles on hydrophobicity and transparency of polydimethylsiloxanes coatings hybridized with silicon dioxide nanoparticles. Thin solid films, 828, 140800. https://doi.org/10.1016/j.tsf.2025.140800

  28. [28] Niknejad, K., Sharifzadeh Baei, M., & Motallebi Tala Tapeh, S. (2018). Synthesis of metformin hydrochloride nanoliposomes: Evaluation of physicochemical characteristics and release kinetics. International journal of nano dimension, 9(3), 298–313. https://dorl.net/dor/20.1001.1.20088868.2018.9.3.9.7

  29. [29] Fazelinejad, A., Behbahani, M., & Harsij, Z. (2024). Utilization of silicon dioxide nanoparticles and silicon salts to enhance astaxanthin production in Haematococcus Pluvialis. Algal research, 82, 103633. https://doi.org/10.1016/j.algal.2024.103633

  30. [30] Hameed, W. A., & Abbas, M. N. (2024). Dyes adsorption from contaminated aqueous solution using SiO2 nanoparticles prepared from extracted tree leaves. Journal of ecological engineering, 25(7), 41-57. http://dx.doi.org/10.12911/22998993/187921

Published

2025-10-22

How to Cite

Motallebi, S. . (2025). Advances in Mesoporous Silica Nanoparticles for Targeted and Controlled Drug Delivery. Biocompounds, 2(4), 212-225. https://doi.org/10.48313/bic.v2i4.49